Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Simon

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Menopause (New York, N.Y.)|June 25, 2011
Future developments in the medical treatment of abnormal uterine bleeding: what can we expect?James A Simon
Menopause (New York, N.Y.)|April 29, 2006
Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptomsJames A Simon,
Obstetrics and Gynecology|June 26, 2018
In ReplyJames A Simon
Nature Reviews. Endocrinology|November 25, 2010
Postmenopausal hormone therapy: risks versus benefits reassessedJames A Simon
Maturitas|April 19, 2011
Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield)James A Simon
Journal of Women'S Health (2002)|August 9, 2011
Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogenJames A Simon
Menopause (New York, N.Y.)|January 9, 2014
What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?James A Simon
Menopause (New York, N.Y.)|January 25, 2020
Depression, anxiety, and "the incredible shrinking vagina"James A Simon
Menopause (New York, N.Y.)|September 14, 2016
The Woman's Health Initiative and one of many unintended consequencesJames A Simon
Menopause (New York, N.Y.)|September 8, 2005
Does osteopenia warrant treatment?James A Simon
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Menopause (New York, N.Y.)|June 25, 2011
Future developments in the medical treatment of abnormal uterine bleeding: what can we expect?James A Simon
Menopause (New York, N.Y.)|April 29, 2006
Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptomsJames A Simon,
Obstetrics and Gynecology|June 26, 2018
In ReplyJames A Simon
Nature Reviews. Endocrinology|November 25, 2010
Postmenopausal hormone therapy: risks versus benefits reassessedJames A Simon
Maturitas|April 19, 2011
Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield)James A Simon
Journal of Women'S Health (2002)|August 9, 2011
Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogenJames A Simon
Menopause (New York, N.Y.)|January 9, 2014
What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?James A Simon
Menopause (New York, N.Y.)|January 25, 2020
Depression, anxiety, and "the incredible shrinking vagina"James A Simon
Menopause (New York, N.Y.)|September 14, 2016
The Woman's Health Initiative and one of many unintended consequencesJames A Simon
Menopause (New York, N.Y.)|September 8, 2005
Does osteopenia warrant treatment?James A Simon
Pageof 19